Prescription Required
Inclusive of all taxes
In Treatment of Moderate to severe pain Mutrans 10mcg/hr Transdermal Patch helps to relieve moderate to severe pain in conditions that affect joints and muscles. It works by blocking those chemical messengers in our body that are responsible for the pain sensation. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis. Applying it will help you go about your daily life more easily. This will help you to go about your daily activities more easily and have a better, more active, quality of life. Consult a doctor if you are not sure. In Treatment of Opioid (Morphine) dependence Opioids are prescribed to treat pain. With prolonged use, the body may become dependent on them and cause withdrawal symptoms, which makes it difficult to stop taking them. Mutrans 10mcg/hr Transdermal Patch helps prevent these cravings that lead to opioid dependence and also helps the person to refrain from taking them repeatedly.
No interaction found/established
Mutrans 10mcg/hr Transdermal Patch may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Mutrans 10mcg/hr Transdermal Patch is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
No interaction found/established
Mutrans 10mcg/hr Transdermal Patch should be used with caution in patients with severe kidney disease. Dose adjustment of Mutrans 10mcg/hr Transdermal Patch may be needed. Please consult your doctor.
Mutrans 10mcg/hr Transdermal Patch should be used with caution in patients with severe liver disease. Dose adjustment of Mutrans 10mcg/hr Transdermal Patch may be needed. Please consult your doctor. Consider the use of an alternate analgesic that may permit more flexibility with the dosing in patients with severe hepatic impairment.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Modi Mundi Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aureate Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zuventus Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sparsha Pharma International Pvt Ltd || ₹14.5/tablet (25% cheaper)